Progressive Myoclonic Epilepsies
Open Access
- 1 January 2002
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 17 (1_suppl) , S80-S84
- https://doi.org/10.1177/08830738020170011201
Abstract
The progressive myoclonic epilepsies are a rare but extremely debilitating group of disorders that are difficult to diagnose and even harder to treat. They represent a heterogeneous subgroup of those with secondary generalized epilepsy. Efficacy of treatment is often measured in terms of slowing a patient's inevitable decline. Reviewed here are the classification of progressive myoclonic epilepsies, features of myoclonic seizures, the five most prevalent progressive myoclonic epilepsy syndromes—Unverricht-Lundborg disease, myoclonus epilepsy with ragged red fibers (MERRF) mitochondrial disease, Lafora's disease, neuronal ceroid lipofuscinoses, and sialidoses—and current treatment options. (J Child Neurol 2002;17: S80—S84).Keywords
This publication has 8 references indexed in Scilit:
- Pheno/genotypic correlations of neuronal ceroid lipofuscinosesNeurology, 2001
- Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 geneAnnals of Neurology, 2001
- Effects of Vagus Nerve Stimulation on Progressive Myoclonus Epilepsy of Unverricht‐Lundborg TypeEpilepsia, 2000
- Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patientsEpilepsy Research, 1998
- Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamideEpilepsy Research, 1998
- Classification of progressive myoclonus epilepsies and related disordersAnnals of Neurology, 1990
- Progressive myoclonus epilepsy treated with zonisamideNeurology, 1988
- Antimyoclonic Action of PiracetamClinical Neuropharmacology, 1986